Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

16.25p
   
  • Change Today:
    -0.50p
  • 52 Week High: 82.00
  • 52 Week Low: 14.67
  • Currency: UK Pounds
  • Shares Issued: 95.31m
  • Volume: 1,536,814
  • Market Cap: £15.49m
  • RiskGrade: 410

Destiny Pharma Overview

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR).

Key Personnel

CEO: Chris Tovey
CFO and Company Secretary: Shaun Claydon
Chief Scientific Officer: William Love
Non-Executive Chairman: Nigel Rudd
Non-Executive Dir: Nigel Brooksby, Debra Barker, James Stearns, Aled Williams

Contact Details

Address: Unit 36 Sussex Innovation Centre, Science Park Square, Falmer, Brighton, United Kingdom, BN1 9SB
Phone: +44 (0)1273 704 440
Website: http://www.destinypharma.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BDHSP575

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 16.25p
Change Today -0.50p
% Change -2.99 %
52 Week High 82.00
52 Week Low 14.67
Volume 1,536,814
Shares Issued 95.31m
Market Cap £15.49m
RiskGrade 410

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.26% below the market average20.26% below the market average20.26% below the market average20.26% below the market average20.26% below the market average
13.73% below the sector average13.73% below the sector average13.73% below the sector average13.73% below the sector average13.73% below the sector average
Price Trend
85.42% below the market average85.42% below the market average85.42% below the market average85.42% below the market average85.42% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Destiny Pharma Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
17:06 11,200 @ 16.25p
16:25 21,465 @ 16.17p
16:22 19 @ 16.50p
16:22 24,605 @ 16.28p
16:09 1,700 @ 16.42p

Destiny Pharma Key Personnel

CEO Chris Tovey

Top of Page